Taclonex Ointment

  • Psoriasis

Taclonex Ointment Generic Name & Formulations

General Description

Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%.

Pharmacological Class

Vit. D3 derivative + topical steroid.

How Supplied

Oint—60g, 100g; Susp—60g, 2x60g


Generic Availability


Taclonex Ointment Indications


Plaque psoriasis.

Taclonex Ointment Dosage and Administration

Adults and Children

<12yrs: not established. Apply to affected areas once daily for up to 4 weeks; discontinue when control is achieved. 12–17yrs: max 60g/wk. ≥18yrs: max 100g/wk. Limit treatment area to max 30% body surface area. Do not occlude.

Taclonex Ointment Contraindications

Not Applicable

Taclonex Ointment Boxed Warnings

Not Applicable

Taclonex Ointment Warnings/Precautions


Avoid use near eyes, on face, groin, or axillae, or if atrophy is present at treatment site. Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Avoid sun, UV light (eg, phototherapy). Allergic contact dermatitis. Pregnancy. Nursing mothers.

Taclonex Ointment Pharmacokinetics

See Literature

Taclonex Ointment Interactions


Systemic absorption potentiated by other corticosteroids.

Taclonex Ointment Adverse Reactions

Adverse Reactions

Oint: pruritus, scaly rash. Susp: folliculitis, burning sensation of skin.

Taclonex Ointment Clinical Trials

See Literature

Taclonex Ointment Note

Not Applicable

Taclonex Ointment Patient Counseling

See Literature